Instil Bio, Inc.

TIL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $5.5M $5.0M $6.6M $5.8M $7.7M $15.4M $8.8M $6.7M
Accounts Receivable
Inventory
Total Current Assets $71.6M $188.3M $191.4M $196.3M $207.4M $219.3M $124.5M $132.6M
Property, Plant & Equipment $111.8M $112.0K $126.0K $138.0K $150.0K $162.0K $129.4M $130.1M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $197.7M $200.4M $203.5M $211.8M $231.0M $237.4M $263.6M $272.6M
Liabilities
Accounts Payable $795.0K $793.0K $779.0K $928.0K $523.0K $286.0K $659.0K $1.2M
Total Current Liabilities $3.3M $4.7M $4.8M $5.7M $13.9M $7.2M $7.9M $10.3M
Long-Term Debt
Total Liabilities $90.3M $89.7M $89.7M $91.3M $99.3M $92.5M $94.1M $96.2M
Stockholders' Equity
Retained Earnings $-735.0M $-730.7M $-726.5M $-718.3M $-704.7M $-683.3M $-655.1M $-643.2M
Total Stockholders' Equity $107.4M $110.7M $113.9M $120.4M $131.7M $144.9M $169.4M $176.3M
← Newer Page 1 of 4 Older →